$ABUS
Arbutus Biopharma Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.58
▲+2.92%+$0.130
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateArbutus Biopharma Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ABUS up today? It is at $4.58 (+2.92%), and our scanner flagged it 113 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABUS spikes, and full due diligence on ABUS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ABUS 113 times in the last 30 days. Create a free account to track $ABUS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ABUS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 12 unusual-volume and momentum alerts on ABUS today, peaking at 14.1x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Beardsley Robert A Director | Sold (automatic/other) | -99K 0.05% of company | sold 75% | 32K | $502K at $5.07 | Sep 18, 26 |
Beardsley Robert A Director | Other | 131K 0.07% of company | n/a | 131K | $420K at $3.20 | Sep 18, 26 |
Sawhney Roger Director | Sold (automatic/other) | -101K 0.05% of company | sold 77% | 31K | $510K at $5.07 | Sep 18, 26 |
Sawhney Roger Director | Other | 131K 0.07% of company | n/a | 131K | $439K at $3.34 | Sep 18, 26 |
Nguyen Tuan Officer | Sold (automatic/other) | -207K 0.1% of company | sold 56% | 160K | $1.0M at $5.07 | Sep 18, 26 |
Nguyen Tuan Officer | Other | 293K 0.1% of company | added 100% | 367K | $1.0M at $3.49 | Sep 18, 26 |
Androski Lindsay Officer | Sold (automatic/other) | -83K 0.04% of company | sold 53% | 72K | $418K at $5.07 | Sep 18, 26 |
Androski Lindsay Officer | Other | 127K 0.06% of company | added 100% | 155K | $406K at $3.20 | Sep 18, 26 |
Androski Lindsay Officer | Acquired (grant/award) | +28K 0.01% of company | n/a | 28K | n/a | Feb 2, 26 |
Nguyen Tuan Officer | Acquired (grant/award) | +74K 0.04% of company | n/a | 74K | n/a | Feb 2, 26 |
Sims Karen Officer | Acquired (grant/award) | +49K 0.02% of company | added 46% | 155K | n/a | Feb 14, 25 |
Hastings David C Officer | Acquired (grant/award) | +90K 0.05% of company | added 56% | 250K | n/a | Feb 14, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
ABUS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 12 unusual-volume and momentum alerts on ABUS today, peaking at 14.1x its normal volume.
ABUS last traded at $4.58, up 2.92% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Arbutus Biopharma Corporation Common Stock (ABUS) is next expected to report earnings on Thursday, November 12, 2026, about 38 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ABUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABUS 113 times in the last 30 days.
ABUS (Arbutus Biopharma Corporation Common Stock) trades on XNAS, with a market cap of about $880M in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABUS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ABUS discussion
Sign in to ask a question or join the discussion.